These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 22093636

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB, Timcheva KV, Hadjiolov ND.
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [Abstract] [Full Text] [Related]

  • 3. [Predicative value of 99mTc-MIBI scintimammography in neoadjuvant chemotherapeutic effect of patients with operable breast cancer].
    Liu ZZ, Lu ZD, Liu H, Li LF, Zhang HW, Yang H, Li WL, Cui SD.
    Zhonghua Yi Xue Za Zhi; 2011 Feb 15; 91(6):382-4. PubMed ID: 21418909
    [Abstract] [Full Text] [Related]

  • 4. Tc-99m sestamibi scintimammography in the evaluation of response of breast carcinoma to chemotherapy.
    Joaquim AI, Sagarra AJ, Ramos CD, Coudry R, Sagarra RA, Camargo EE.
    Clin Nucl Med; 1997 Sep 15; 22(9):638-40. PubMed ID: 9298303
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
    Zaman MU, Nasir Z, Raza T, Hashmi H, Hashmi A, Fatima N.
    J Coll Physicians Surg Pak; 2009 Mar 15; 19(3):173-8. PubMed ID: 19268018
    [Abstract] [Full Text] [Related]

  • 10. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC, Gallego-Peinado M, Menjón-Beltrán S, García-García J, Pastor-Pons E, Chamorro-Santos CE, Ramos-Font C, Salamanca-Ballesteros A, Llamas-Elvira JM, Olea-Serrano N.
    Rev Esp Med Nucl Imagen Mol; 2012 Mar 15; 31(3):117-23. PubMed ID: 21676504
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
    Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, Botti G, D'Aiuto G, Salvatore M.
    J Clin Oncol; 1998 May 15; 16(5):1677-83. PubMed ID: 9586878
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ, Kolotas C, Filipowicz I, Kurek R, Kuner RP, Martin T, Baltas D, Rogge B, Kontova M, Hoffmann G, Pollow B, Zamboglou N.
    Strahlenther Onkol; 2006 Jan 15; 182(1):22-9. PubMed ID: 16404517
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer].
    Wang B, Fu JF, Hong ZW.
    Ai Zheng; 2009 Mar 15; 28(3):292-6. PubMed ID: 19619445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.